Clinical Trial Update: Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing the safety and dosing of the combination of bortezomib and gemcitabine in older patients with advanced solid tumors, spanning multiple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Head and Neck Cancer
• Kidney Cancer
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• Bortezomib (bortezomib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Masonic Cancer Center, University of Minnesota | Conditions: Breast Cancer, Colorectal Cancer | Phase 1 | Status: COMPLETED